BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdin A, Anker SD, Butler J, Coats AJS, Kindermann I, Lainscak M, Lund LH, Metra M, Mullens W, Rosano G, Slawik J, Wintrich J, Böhm M. 'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor. ESC Heart Fail 2021. [PMID: 34655282 DOI: 10.1002/ehf2.13646] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Luedike P, Papathanasiou M, Schmack B, Kamler M, Perings C, Ruhparwar A, Rassaf T. Structural components for the development of a heart failure network. ESC Heart Failure 2022. [DOI: 10.1002/ehf2.14266] [Reference Citation Analysis]
2 Abdin A, Bauersachs J, Soltani S, Eden M, Frey N, Böhm M. A practical approach to the guideline-directed pharmacological treatment of heart failure with reduced ejection fraction. ESC Heart Fail 2023;10:24-31. [PMID: 36229988 DOI: 10.1002/ehf2.14197] [Reference Citation Analysis]
3 Abdin A, Barakat A, Alsaadi AR, Katbeh A, Bani Marjeh Y, Bekfani T, Alachkar MN. Application of recommended therapies among patients with heart failure during the Syrian conflict: reality and barriers. ESC Heart Fail 2022;9:4003-9. [PMID: 35996985 DOI: 10.1002/ehf2.14119] [Reference Citation Analysis]
4 Abdin A, Schulz M, Riemer U, Hadëri B, Wachter R, Laufs U, Bauersachs J, Kindermann I, Vukadinović D, Böhm M. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials. ESC Heart Fail 2022;9:3737-50. [PMID: 35921043 DOI: 10.1002/ehf2.14097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fantin F, Giani A, Franconi A, Zoico E, Urbani S, Rossi AP, Mazzali G, Zamboni M. Arterial Stiffness, Subendocardial Impairment, and 30-Day Readmission in Heart Failure Older Patients. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.918601] [Reference Citation Analysis]
6 Supples M, Jelden K, Pallansch J, Russell FM. Prehospital Diagnosis and Treatment of Patients With Acute Heart Failure. Cureus 2022. [DOI: 10.7759/cureus.25866] [Reference Citation Analysis]
7 Di Fusco SA, Gronda E, Mocini E, Lucà F, Bisceglia I, De Luca L, Caldarola P, Cipriani M, Corda M, De Nardo A, Francese GM, Napoletano C, Navazio A, Riccio C, Roncon L, Tizzani E, Nardi F, Urbinati S, Valente S, Gulizia MM, Gabrielli D, Oliva F, Imperoli G, Colivicchi F. ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation. Eur Heart J Suppl 2022;24:C272-7. [PMID: 35602255 DOI: 10.1093/eurheartj/suac017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maizels L, Wasserstrum Y, Fishman B, Segev A, Ben-Nun D, Younis A, Freimark D, Mazin I, Grupper A. Characterization of heart failure patients with reverse left ventricular remodelling post-angiotensin receptor blockers/neprilysin inhibitors therapy. ESC Heart Fail 2022. [PMID: 35178886 DOI: 10.1002/ehf2.13801] [Reference Citation Analysis]